Inogen | INGN - تكلفة المبيعات





تكلفة المبيعات تغيير تاريخ
Abbott USD 5.94B 642M 2026-06
Accuray USD 116.17M 14.63M 2024-12
AngioDynamics USD 37.29M 786K 2025-09
Artivion USD 42.85M 3.86M 2025-12
AtriCure USD 34.98M 3.04M 2026-06
Baxter International USD 1.93B 118M 2026-06
Becton, Dickinson and Co. USD 2.67B 108M 2026-06
Boston Scientific USD 1.86B 29M 2026-06
Cooper Companies USD 393.8M 17M 2026-03
Dexcom USD 478.4M 36.8M 2026-06
Edwards Lifesciences USD 392.4M 29.8M 2026-06
Globus Medical USD 271M 7.41M 2026-06
Inogen USD 39.59M 1.27M 2024-09
Insulet USD 239.1M 6.4M 2026-06
Medtronic USD 3.8B 195M 2026-03
Orthofix International USD 66.63M 6.4M 2025-12
Philips EUR 2.21B 70M 2026-06
ResMed USD 612.93M 61.26M 2026-06
Steris USD 808.6M 82.7M 2026-06
Stryker USD 2.26B 106M 2026-06
Tandem Diabetes Care USD 109.78M 653K 2026-06
Teleflex USD 238.62M 2.21M 2026-06
X T L Biopharmaceuticals USD 332K 216K 2024-12
Zimmer Biomet Holdings USD 815.9M 77.6M 2026-06